Here are what the editors at HealthDay consider to be the most important developments in Dermatology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Bariatric Surgery Linked to Reduced Risk for Skin Cancer
THURSDAY, Oct. 31, 2019 (HealthDay News) — For individuals with obesity, bariatric surgery is associated with a reduced risk for skin cancer, including melanoma, according to a study published online Oct. 30 in JAMA Dermatology.
Survey Reveals Many Americans Lack Cancer Prevention Knowledge
WEDNESDAY, Oct. 30, 2019 (HealthDay News) — Only one in four U.S. adults report incorporating cancer prevention into their daily lives, according to the results of the American Society of Clinical Oncology 2019 National Cancer Opinion Survey.
CDC: U.S. Life Expectancy Up Slightly, Mortality Lower in 2017
WEDNESDAY, Oct. 30, 2019 (HealthDay News) — Life expectancy has increased slightly in the United States, and mortality is lower than in 2007, according to a report published Oct. 30 by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Facebook Launches Preventive Health Tool
TUESDAY, Oct. 29, 2019 (HealthDay News) — A new tool designed to help guide preventive care for heart disease, cancer, and seasonal flu was launched in the United States Monday by Facebook.
Outcomes Poor With Medical Care From Fraud, Abuse Perpetrators
MONDAY, Oct. 28, 2019 (HealthDay News) — Receiving medical care from fraud and abuse perpetrators (FAPs), subsequently excluded from Medicare, is associated with higher rates of all-cause mortality and emergency hospitalization, according to a study published online Oct. 28 in JAMA Internal Medicine.
Doctors Mostly Dissatisfied With Electronic Health Record Systems
MONDAY, Oct. 28, 2019 (HealthDay News) — The majority of physicians are dissatisfied with their current electronic health record (EHR) systems, according to survey results released Oct. 16 by Medical Economics.
SunSmart Program Ups Sun Protection Behaviors
MONDAY, Oct. 28, 2019 (HealthDay News) — A skin cancer prevention program — “SunSmart” — can create lasting changes in sun protection behavior and contribute to the decline in melanoma rates, according to a study published online Oct. 8 in PLOS Medicine.
Poor Health Literacy Tied to More Hardships Among Cancer Survivors
WEDNESDAY, Oct. 23, 2019 (HealthDay News) — Health insurance literacy may be an important intervention for addressing financial problems associated with cancer, according to a study published online Oct. 21 in JNCI Cancer Spectrum.
Outcomes Across Nonmelanoma Skin Cancer Treatments Similar
WEDNESDAY, Oct. 23, 2019 (HealthDay News) — Outcomes for nonmelanoma skin cancers are similar at one year, regardless of treatment type, although cosmetic results vary, according to a review published in the Oct. 15 issue of Cancer.
More Choices, Lower Premiums for ACA Consumers Next Year
TUESDAY, Oct. 22, 2019 (HealthDay News) — There will be more health insurance choices and a slight decrease in premiums for many consumers next year under the Affordable Care Act, according to the Trump administration.
Expert Second Opinions Up Reliability of Melanoma Diagnosis
TUESDAY, Oct. 22, 2019 (HealthDay News) — Second opinions rendered by dermatopathologists improve the reliability of melanocytic lesion diagnosis, although there is still discordance among pathologists, according to a study published online Oct. 11 in JAMA Network Open.
Risk for Cancer Incidence, Mortality Increased With Psoriasis
WEDNESDAY, Oct. 16, 2019 (HealthDay News) — Patients with psoriasis have an increased risk for developing or dying from cancer, according to a review published online Oct. 16 in JAMA Dermatology.
Rates of Head, Neck Melanoma Up in North American Youth
TUESDAY, Oct. 15, 2019 (HealthDay News) — From 1995 to 2014, there was a 51.1 percent increase in the incidence of pediatric, adolescent, and young adult head and neck melanoma in North America, according to a study published online Oct. 3 in JAMA Otolaryngology-Head & Neck Surgery.
Patient Portal Use Has Positive Impact on Preventive Health Behaviors
FRIDAY, Oct. 11, 2019 (HealthDay News) — Patient portal use has a positive impact on preventive health behaviors, but not on chronic health outcomes, according to a study published in the October issue of the Journal of Medical Internet Research.
Medicare Fraud-Prevention Rules to Be Revised
WEDNESDAY, Oct. 9, 2019 (HealthDay News) — Revision of decades-old Medicare rules meant to prevent fraud has been proposed by the Trump administration.
2000 to 2015 Saw Increase in Medicare GME Payments
WEDNESDAY, Oct. 9, 2019 (HealthDay News) — Medicare graduate medical education (GME) payments increased significantly from 2000 to 2015, according to a study published online Oct. 7 in JAMA Internal Medicine.
Burnout Linked to Poor Quality Care in Published Literature
TUESDAY, Oct. 8, 2019 (HealthDay News) — In the published literature, burnout in health care professionals is frequently associated with poor-quality care, but the effect size may be smaller than reported, according to data from a systematic review published online Oct. 8 in the Annals of Internal Medicine.
Cost of Waste in U.S. Health System Estimated
TUESDAY, Oct. 8, 2019 (HealthDay News) — The estimated cost of waste in the U.S. health care system varies from $760 to $935 billion, according to a special communication published online Oct. 7 in the Journal of the American Medical Association.
Indoor Tanning May Up Risk for Squamous Cell Carcinoma
MONDAY, Oct. 7, 2019 (HealthDay News) — There is a dose-response association between indoor tanning and risk for cutaneous squamous cell carcinoma in women, according to a study published online Oct. 2 in JAMA Dermatology.
United States Will Keep Measles Elimination Status
THURSDAY, Oct. 3, 2019 (HealthDay News) — Despite recent outbreaks among unvaccinated people, the U.S. Centers for Disease Control and Prevention expects the United States will maintain its measles elimination status.
Ligelizumab Safely, Effectively Treats Hives
THURSDAY, Oct. 3, 2019 (HealthDay News) — Ligelizumab appears to be a safe and effective treatment option for chronic spontaneous urticaria, according to a study published in the Oct. 3 issue of the New England Journal of Medicine.
Copyright © 2019 ScoutNews, LLC. All rights reserved.